SUMIT K. SUBUDHI to Urogenital Neoplasms
This is a "connection" page, showing publications SUMIT K. SUBUDHI has written about Urogenital Neoplasms.
Connection Strength
0.358
-
Evaluation of Technology-Enabled Monitoring of Patient-Reported Outcomes to Detect and Treat Toxic Effects Linked to Immune Checkpoint Inhibitors. JAMA Netw Open. 2021 08 02; 4(8):e2122998.
Score: 0.180
-
Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events. J Immunother Cancer. 2021 07; 9(7).
Score: 0.178